nti_article_01

Leversense

Leversense is commercializing an innovative new method for in vitro diagnostics technology. The technology, licensed from Drexel University, is a solid-state electromechanical sensor technology used to detect protein, nucleic acid and pathogen disease indicators. Ben Franklin Technology Partners of Southeastern PA has also invested $500,000 in the company.

www.leversense.com

The Promise of Nanotechnology

“The use of nanotechnology in consumer products and industrial applications is growing rapidly, with the products listed in the inventory showing just the tip of the iceberg.  How consumers respond to these early products — in food, electronics, health care, clothing and cars — will be a litmus test for broader market acceptance of nanotechnologies in the future.”

–Andrew D. Maynard
Chief Science Advisor, Project on Emerging Nanotechnologies
Woodrow Wilson International Center for Scholars